Akums secures European CEP approval for Cefpodoxime Proxetil

The approval is expected to support the company’s presence in regulated international markets and further strengthen its position as a reliable pharma manufacturing partner

Intracin Pharma secures APVMA nod to supply veterinary medicines in Australia

Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market

Alkem launches single-shot Semaglutide pre-filled syringes at Rs. 350

DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability

Cipla appoints Taher Karampurwala as Senior Director and Head of Middle East Business

Veteran pharmaceutical executive to relocate to Saudi Arabia and spearhead Cipla’s growth strategy across the Middle East region

Aragen Life Sciences elevates Pavan Kumar Kamarajugadda to Senior Director

Servier to acquire Edgewise muscular dystrophy business in $2.65 billion deal

The transaction includes an upfront payment of $1.55 billion, along with up to $1.1 billion in regulatory and commercial milestone payments

Virohan launches Rs. 2 crore scholarship to promote health education among women

The initiative opens pathways for female students to pursue healthcare programs across 20+ top universities and colleges in India

CORONA Remedies receives EU-GMP certification for hormone facility

Accreditations for Bhayla manufacturing site strengthen the company’s global quality credentials and support expansion of its hormone portfolio into regulated international markets

Ebola vax on the anvil?

CEPI will commit up to US $50 million to fund preclinical research and Phase 1 clinical trials of Moderna’s mRNA-based vaccine candidate

FDA okays AstraZeneca’s bladder cancer drug Imfinzi Plus BCG

First immunotherapy combination approved in the US for BCG-naïve high-risk NMIBC demonstrates a 32% reduction in the risk of disease recurrence, progression, or death